Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Massey

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Seminars in Oncology|August 2, 2020
Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemicPaul R Massey, Krystal M Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patientsVinay Prasad, Paul R Massey, Tito Fojo
The Physician and Sportsmedicine|March 1, 2013
Eminence-based medicine versus evidence-based medicine: is anterior cruciate ligament reconstruction optimally performed with the double-bundle technique?Paul R Massey, Fotios P Tjoumakaris, Joseph Bernstein
Cancer Biology & Therapy|May 29, 2015
Multiplying therapies and reducing toxicity in metastatic melanomaPaul R Massey, Vinay Prasad, William D Figg, et al.
Plos One|August 31, 2013
Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivityCourtney W Mangus, Paul R Massey, Daniel H Fowler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 5, 2014
Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literaturePaul R Massey, Jonathan S Okman, Julia Wilkerson, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 30, 2010
ABC transporters: unvalidated therapeutic targets in cancer and the CNSRobert W Robey, Paul R Massey, Laleh Amiri-Kordestani, et al.
The Oncologist|February 19, 2016
Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology MeetingPaul R Massey, Ruibin Wang, Vinay Prasad, et al.
The Journal of Investigative Dermatology|March 27, 2021
Differential Molecular Expression Patterns Associated with Metastasis in Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-AnalysisPatrick M Mulvaney, Paul R Massey, Kenneth K Yu, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 9, 2021
Practice Variation in Utilization of Flap or Graft Reconstruction Among Veterans Affairs Surgeons After Extirpation of Keratinocyte Carcinoma on the NosePaul R Massey, Brooke E Rothstein, Sameer Gupta, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|August 2, 2020
Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemicPaul R Massey, Krystal M Jones
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patientsVinay Prasad, Paul R Massey, Tito Fojo
The Physician and Sportsmedicine|March 1, 2013
Eminence-based medicine versus evidence-based medicine: is anterior cruciate ligament reconstruction optimally performed with the double-bundle technique?Paul R Massey, Fotios P Tjoumakaris, Joseph Bernstein
Cancer Biology & Therapy|May 29, 2015
Multiplying therapies and reducing toxicity in metastatic melanomaPaul R Massey, Vinay Prasad, William D Figg, et al.
Plos One|August 31, 2013
Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivityCourtney W Mangus, Paul R Massey, Daniel H Fowler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 5, 2014
Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literaturePaul R Massey, Jonathan S Okman, Julia Wilkerson, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 30, 2010
ABC transporters: unvalidated therapeutic targets in cancer and the CNSRobert W Robey, Paul R Massey, Laleh Amiri-Kordestani, et al.
The Oncologist|February 19, 2016
Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology MeetingPaul R Massey, Ruibin Wang, Vinay Prasad, et al.
The Journal of Investigative Dermatology|March 27, 2021
Differential Molecular Expression Patterns Associated with Metastasis in Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-AnalysisPatrick M Mulvaney, Paul R Massey, Kenneth K Yu, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 9, 2021
Practice Variation in Utilization of Flap or Graft Reconstruction Among Veterans Affairs Surgeons After Extirpation of Keratinocyte Carcinoma on the NosePaul R Massey, Brooke E Rothstein, Sameer Gupta, et al.
Pageof 3